Institutional Ownership Neurosense Therapeutics LTD Wt (NRSNW)
This table provides information about the institutional ownership of Neurosense Therapeutics LTD Wt (NRSNW). We have compiled data on the 6 institutions that hold shares in the stock, with a total of 271,434 shares, which have been reported (via 13F filing form) to have a value of $54,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
160,000
shares
|
$32,000
0.28% of portfolio
|
Q4 2021
New holding
|
|
|
Clear Street LLC
|
Nov 14, 2024 Q3 2024 |
65,759
shares
|
$13,151
0.0% of portfolio
|
Q3 2024
Added 10.94%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
25,274
shares
|
$5,054
0.0% of portfolio
|
Q3 2024
Reduced 14.22%
|
|
|
Warberg Asset Management LLC
Winnetka, IL |
Nov 06, 2024 Q3 2024 |
20,201
shares
|
$4,040
0.02% of portfolio
|
Q3 2024
Reduced 36.88%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
200
shares
|
$40
0.0% of portfolio
|
Q3 2024
Reduced 66.94%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|